Evidence map›Paper›PMID 41003410›Full record

ArticleJournal of functional biomaterials2025

Impact of 45S5-Bioactive Glass on Chondrocytes in Knee Osteoarthritis-In Vitro Study Exploring Cellular Responses.

Max Marinescu, Sébastien Hagmann, Jörg Fellenberg, Elena Tripel, Simone Gantz, Ravikumar Mayakrishnan, Aldo R Boccaccini, Tobias Renkawitz, Babak Moradi, Fabian Westhauser and 1 more

Abstract read
In one paragraph

Article in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Max MarinescuDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.ORCID 0009-0009-0997-8367
Sébastien HagmannDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.
Jörg FellenbergDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.ORCID 0000-0002-6187-6474
Elena TripelDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.
Simone GantzOrthopedic Research Center, Kiel University, 24118 Kiel, Germany.ORCID 0009-0006-2075-9550
Ravikumar MayakrishnanOrthopedic Research Center, Kiel University, 24118 Kiel, Germany.ORCID 0000-0001-8195-3185
Aldo R BoccacciniInstitute of Biomaterials, University of Erlangen-Nuremberg, 91085 Erlangen, Germany.ORCID 0000-0002-7377-2955
Tobias RenkawitzDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.
Babak MoradiOrthopedic Research Center, Kiel University, 24118 Kiel, Germany.ORCID 0000-0003-1714-2171
Fabian WesthauserDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.
Hadrian PlatzerDepartment of Orthopaedics, Heidelberg University Hospital, 69118 Heidelberg, Germany.ORCID 0000-0001-9805-3810

Funding

Deutsche Arthrose-Hilfe P515-A623
6 · The paper itself

Abstract

Osteoarthritis (OA), the most common joint disease, is marked by cartilage degradation and chronic inflammation. While 45S5-bioactive glass (45S5-BG) is well-established in bone regeneration and has been suggested to exert immunomodulatory effects, its impact on OA chondrocytes remains largely unexplored. Therefore, this in vitro study investigated the effects of 45S5-BG microparticles (0.125 mg/mL) on chondrocytes derived from OA patients, evaluating its therapeutic potential in OA. Chondrocytes were cultured with or without 45S5-BG for 1 and 7 days. Gene expression of cartilage markers, cytokines, matrix metalloproteinases (MMPs), and toll-like receptors (TLRs) was analyzed by qPCR. Protein levels were assessed by ELISA. 45S5-BG stimulation significantly altered chondrocyte activity, inducing upregulation of IL-6, IL-1β, TNF-α, MMP-1/-3/-13, and TLR4. Expression of ACAN and COL2A1 was reduced, while COL10A1-a marker of chondrocyte hypertrophy-was significantly increased at day 1. These findings show a catabolic and pro-inflammatory shift in chondrocyte phenotype upon 45S5-BG exposure, showing no therapeutic benefit of 45S5-BG on OA chondrocytes. However, considering the pronounced effects on chondrocyte activity and the well-established bioactivity and biocompatibility of 45S5-BG, our findings suggest that modified BG formulations could be developed to enhance chondroprotective and anti-inflammatory properties, warranting further investigation in co-culture and in vivo models.

Indexed as

45S5-bioactive glasschondrocytescytokinesmatrix metalloproteinasesosteoarthritis

Identifiers

PMID41003410
PMCPMC12470832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.